Chemical Modification of Oligo(Hexamethylene Guanidine): Synthesis of Alkylated Derivatives and Their Estimated Activity Against Mycobacterium Smegmatis


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

It was found that oligo(hexamethylene guanidine) (OHMG) reacted very slowly with unactivated high-molecular-mass alkyl halides (dodecyl chloride), possibly due to steric hindrance and the low nucleophilicity of the guanidine moiety. Therefore, this alkyl halide could not be used to modify OHMG under conventional conditions. Ethylation of OHMG was much more facile. However, the substitution in the derivatives was broadly scattered (under ordinary conditions and reagent ratios). It was shown simultaneously that the antibacterial activity of the alkylated derivatives was less than that of the starting OHMG hydrochloride. Benzyl chloride reacted readily with OHMG to produce derivatives with the desired degree of substitution. It was found that benzyl derivatives with 0.2 degree of substitution were more active against mycobacteria than the starting hydrochloride with the activity gradually diminishing if the degree of substitution was increased further. The increased activity may have been related to the optimum increase of OHMG hydrophobicity and/or steric structure. The rather high antibacterial activities of the benzyl derivatives against Mycobacterium smegmatis strain ATCC 607 made them promising for further development and studies of the properties of alkylated OHMG derivatives to discover more active derivatives, including against M. smegmatis. The most obvious candidates could become the methylcarboxy-substituted OHMG derivatives.

Об авторах

S. Kedik

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Email: shatalov_d@mirea.ru
Россия, 86 Prosp. Vernadskogo, Moscow, 119571

D. Shatalov

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Автор, ответственный за переписку.
Email: shatalov_d@mirea.ru
Россия, 86 Prosp. Vernadskogo, Moscow, 119571

A. Askretkov

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Email: shatalov_d@mirea.ru
Россия, 86 Prosp. Vernadskogo, Moscow, 119571

P. Isaikina

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Email: shatalov_d@mirea.ru
Россия, 86 Prosp. Vernadskogo, Moscow, 119571

I. Sedishev

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Email: shatalov_d@mirea.ru
Россия, 86 Prosp. Vernadskogo, Moscow, 119571

A. Panov

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Email: shatalov_d@mirea.ru
Россия, 86 Prosp. Vernadskogo, Moscow, 119571

A. Evseeva

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Email: shatalov_d@mirea.ru
Россия, 86 Prosp. Vernadskogo, Moscow, 119571

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML

© Springer Science+Business Media, LLC, part of Springer Nature, 2017

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).